BACK
TO MAIN
PAGE

Hepatitis B​

General Information

Hepatitis B is a viral infection that attacks the liver and can cause both acute and chronic disease.

The virus is most commonly transmitted from mother to child during birth and delivery, as well as through contact with blood or other body fluids, unsafe injections or exposures to sharp instruments.

Hepatitis B can be prevented by vaccines that are safe, available and effective.

WHO recommends that all infants receive the hepatitis B vaccine as soon as possible after birth, preferably within 24 hours, followed by 2 or 3 doses of hepatitis B vaccine at least 4 weeks apart to complete the vaccination series. Protection lasts at least 20 years and is probably lifelong.

Show More

Epidemiology

2019

WHO estimates that 296 million people were living with chronic hepatitis B infection in 2019, with 1.5 million new infections each year.

In 2019, hepatitis B resulted in an estimated 820,000 deaths, mostly from cirrhosis and hepatocellular carcinoma (primary liver cancer).

Vaccines
Pipeline

2
Vaccines in
the pipeline

Technology Platforms

  • Multiple platforms (1)
  • Virus-like particle​ (1)

DEVELOPMENT PHASES

  • Phase II (2)

TRIAL POPULATION

  • Adults (2)

Source: 
https://www.who.int/news-room/fact-sheets/detail/hepatitis-b
[Accessed: November 2022]

Vaccines Europe Pipeline Review

Download our pipeline review